Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Taned Chitapanarux, Nirush Lertprasertsuke & Acharaporn Kongnak. (2019) Teprenone for the prevention of low-dose aspirin-induced gastric mucosal injury in Helicobacter pylori-negative patients. Scandinavian Journal of Gastroenterology 54:10, pages 1199-1204.
Read now
Read now
Arvind Thakkar, Sushma Chenreddy, Astrid Thio, Wael Khamas, Jeffrey Wang & Sunil Prabhu. (2016) Preclinical systemic toxicity evaluation of chitosan-solid lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c mice. International Journal of Nanomedicine 11, pages 3265-3276.
Read now
Read now
Marie Lordkipanidzé. (2012) Advances in monitoring of aspirin therapy. Platelets 23:7, pages 526-536.
Read now
Read now
Neville D Yeomans. (2011) Reducing the risk of gastroduodenal ulcers with a fixed combination of esomeprazole and low-dose acetyl salicylic acid. Expert Review of Gastroenterology & Hepatology 5:4, pages 447-455.
Read now
Read now
Articles from other publishers (18)
Ming-Chou Ku, Yuan-Hsin Tsai, Po-Cheng Cheng, Ting-I Yang, Hui-Wen Ho, Min-Fei Liao, Yu-Tzu Tseng, Ming-Tsung Lee & Yen-Nien Chen. (2022) After Total Knee Arthroplasty, Monitored Active Ankle Pumping Improves Lower Leg Circulation More Than Unmonitored Pumping: A Pilot Study. Applied Sciences 12:18, pages 9028.
Crossref
Crossref
Heung Up Kim. (2019) Can Helicobacter pylori Infection Accelerate the Healing of Nonsteroidal Anti-inflammatory Drugs-induced Peptic Ulcer and Bleeding?. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 19:1, pages 1-4.
Crossref
Crossref
Justin CH Ng & Neville David Yeomans. (2018)
Helicobacter pylori
infection and the risk of upper gastrointestinal bleeding in low dose aspirin users: systematic review and meta‐analysis
. Medical Journal of Australia 209:7, pages 306-311.
Crossref
Crossref
Lei Wen. (2017) Upper Gastrointestinal Complications and Cardiovascular/Gastrointestinal Risk Calculator in Patients with Myocardial Infarction Treated with Aspirin. Chinese Medical Journal 130:16, pages 1909-1913.
Crossref
Crossref
Katarzyna Palus & Jarosław Całka. (2015) The Influence of Prolonged Acetylsalicylic Acid Supplementation-Induced Gastritis on the Neurochemistry of the Sympathetic Neurons Supplying Prepyloric Region of the Porcine Stomach. PLOS ONE 10:11, pages e0143661.
Crossref
Crossref
C Sostres, P Carrera-Lasfuentes, R Benito, P Roncales, M Arruebo, M T Arroyo, L Bujanda, L A García-Rodríguez & A Lanas. (2015) Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users. American Journal of Gastroenterology 110:5, pages 684-689.
Crossref
Crossref
María E. Sáez, Antonio González-Pérez, Saga Johansson, Péter Nagy & Luis A. García Rodríguez. (2014) Patterns in the Use of Low-Dose Acetylsalicylic Acid and Other Therapies Following Upper Gastrointestinal Bleeding. American Journal of Cardiovascular Drugs 14:6, pages 443-450.
Crossref
Crossref
Florence Folmer, Umesh Basavaraju, Marcel Jaspars, Georgina Hold, Emad El-Omar, Mario Dicato & Marc Diederich. (2013) Anticancer effects of bioactive berry compounds. Phytochemistry Reviews 13:1, pages 295-322.
Crossref
Crossref
Gilberto Couto. (2013) Baixa taxa de gastroproteção em doentes de risco sob terapêutica com anti-inflamatórios não esteroides. GE Jornal Português de Gastrenterologia 20:6, pages 237-239.
Crossref
Crossref
Rubén Casado-Arroyo, Carlos Sostres & Angel Lanas. (2013) Optimizing the Use of Aspirin for Cardiovascular Prevention. Drugs 73:8, pages 803-814.
Crossref
Crossref
A. Lanas, M. Polo‐Tomás & R. Casado‐Arroyo. (2013) The aspirin cardiovascular/gastrointestinal risk calculator ‐ a tool to aid clinicians in practice. Alimentary Pharmacology & Therapeutics 37:7, pages 738-748.
Crossref
Crossref
Wolfgang Lösche, Janina Boettel, Björn Kabisch, Johannes Winning, Ralf A. Claus & Michael Bauer. (2012) Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?. Thrombosis 2012, pages 1-8.
Crossref
Crossref
En–Ling Leung Ki & Francis K.L. Chan. (2012) Helicobacter pylori Infection and Nonsteroidal Anti-inflammatory Drug Use: Eradication, Acid-Reducing Therapy, or Both?. Clinical Gastroenterology and Hepatology 10:8, pages 831-836.
Crossref
Crossref
Carlos Sostres & Carla J. Gargallo. (2012) Gastrointestinal lesions and complications of low-dose aspirin in the gastrointestinal tract. Best Practice & Research Clinical Gastroenterology 26:2, pages 141-151.
Crossref
Crossref
Rubén Casado-Arroyo, Carla Gargallo & Ángel Lanas Arbeloa. (2012) Balancing the risk and benefits of low-dose aspirin in clinical practice. Best Practice & Research Clinical Gastroenterology 26:2, pages 173-184.
Crossref
Crossref
En-ling Leung Ki & Francis K.L. Chan. (2012) Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: Implications for clinical practice. Best Practice & Research Clinical Gastroenterology 26:2, pages 163-172.
Crossref
Crossref
Rubén Casado-Arroyo, María Muñoz-Villalenguas & Ángel Lanas Arbeloa. (2011) Antiagregantes plaquetarios e inhibidores de la bomba de protones. ¿Cómo optimizar el riesgo-beneficio en los pacientes con riesgo cardiovascular y riesgo de hemorragia gastrointestinal?. Gastroenterología y Hepatología 34:7, pages 478-491.
Crossref
Crossref
Carlos Sostres & Angel Lanas. (2011) Gastrointestinal effects of aspirin. Nature Reviews Gastroenterology & Hepatology 8:7, pages 385-394.
Crossref
Crossref